Exposure of medical students to pharmaceutical marketing in primary care settings: Frequent and influential

Advances in Health Sciences Education

Volumn 14, Issue 5, 2009, Pages 713-724

  Sarikaya, Ozlem ^a   Civaner, Murat ^b   Vatansever, Kevser ^c  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Conflict of interest; Drug industry relationships; Marketing methods; Pharmaceutical representatives; Primary health care settings

Indexed keywords

ARTICLE; COMMERCIAL PHENOMENA; CONFLICT OF INTEREST; DRUG INDUSTRY; HEALTH PERSONNEL ATTITUDE; HUMAN; MARKETING; MEDICAL STUDENT; PERSUASIVE COMMUNICATION; PRESCRIPTION; PSYCHOLOGICAL ASPECT; PUBLIC RELATIONS; QUESTIONNAIRE; STATISTICAL MODEL;

ATTITUDE OF HEALTH PERSONNEL; COMMERCE; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG PRESCRIPTIONS; HUMANS; INTERPROFESSIONAL RELATIONS; LOGISTIC MODELS; MARKETING; PERSUASIVE COMMUNICATION; QUESTIONNAIRES; STUDENTS, MEDICAL;

EID: 70449124601     PISSN: 13824996     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10459-009-9153-7     Document Type: Article

References (35)

1. Akici, A., et al. (2004). Comparison of rational pharmacotherapy decision-making competence of general practitioners with intern doctors. European Journal of Clinical Pharmacology, 60, 75-82. doi:10.1007/s00228-004-0751-2.
2. Barfett, J., et al. (2004). Pharmaceutical marketing to medical students: The student perspective. McGill Journal of Medicine, 8, 21-27.
3. Bellin, M., et al. (2004). Medical students' exposure to pharmaceutical industry marketing: A survey at one US medical school. Academic Medicine, 79, 1041-1045. doi:10.1097/00001888-200411000-00005.
4. Civaner, M. (2006). The marketing methods of pharmaceutical companies in Turkey and ethical analysis of physicians' arguments on this subject (Unpublished PhD thesis). Dissertation, Ankara University.
5. Cohen, J. J. (2006). Professionalism in medical education, an American perspective: From evidence to accountability. Medical Education, 40, 607-617. doi:10.1111/j.1365-2929.2006.02512.x.
6. Daniel, E. E., & Leedham, L. (1966). Effect on student attitudes of a program of critical evaluation of claims for drugs. Journal of Medical Education, 41, 49-60.
7. de Vries, T. P., et al. (1995). Impact of a short course in pharmacotherapy for undergraduate medical students: An international randomised controlled study. Lancet, 346, 1454-1457. doi:10.1016/S0140-6736(95)92472-8.
8. Dornan, T., & Bundy, C. (2004). What can experience add to early medical education? Consensus survey. British Medical Journal (Clinical Research Ed.), 329, 834. doi:10.1136/bmj.329.7470.834.
9. Garb, S. (1960). Teaching medical students to evaluate drug advertising. Journal of Medical Education, 35, 729-739.
10. Goodman, R. L. (2007). Medical education and the pharmaceutical industry. Perspectives in Biology and Medicine, 50, 32-39. doi:10.1353/pbm.2007.0005.
11. Hafferty, F. W. (1998). Beyond curriculum reform: Confronting medicine's hidden curriculum. Academic Medicine, 73, 403-407. doi:10.1097/00001888-199804000-00013.
12. Hodges, B. (1995). Interactions with the pharmaceutical industry: Experiences and attitudes of psychiatry residents, interns and clerks. Canadian Medical Association Journal, 153, 553-559.
13. Hyman, P. L., et al. (2007). Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry. Academic Medicine, 82, 94-99. doi:10.1097/01.ACM.0000249907.88740.ef.
14. Kumar, C. J., et al. (2006). Awareness and attitudes about disease mongering among medical and pharmaceutical students. PLoS Medicine, 3, e213. doi:10.1371/journal.pmed.0030213.
15. Lexchin, J., et al. (1993). Interactions between physicians and the pharmaceutical industry: What does the literature say? Canadian Medical Association Journal, 149, 1401-1407.
16. Littlewood, S., et al. (2005). Early practical experience and the social responsiveness of clinical education: systematic review. British Medical Journal (Clinical Research Ed.), 331, 387-391. doi:10.1136/bmj.331.7513.387.
17. Miettola, J., et al. (2005). Doctor-patient interaction in Finnish primary health care as perceived by first year medical students. BMC Medical Education, 5, 34. doi:10.1186/1472-6920-5-34.
18. Monaghan, M. S., et al. (2003). Student understanding of the relationship between the health professions and the pharmaceutical industry. Teaching and Learning in Medicine, 15, 14-20. doi:10.1207/S15328015TLM1501_04.
19. Norris, P., et al. (2005). Drug promotion. What we know, what we have yet to learn. Geneva: WHO.
20. Palmisano, P., & Edelstein, J. (1980). Teaching drug promotion abuses to health profession students. Journal of Medical Education, 55, 453-455.
21. Prideaux, D., & Worley, P. (2007). Symbiosis: A new model for clinical education. The Clinical Teacher, 4, 209-212. doi:10.1111/j.1743-498X.2007.00188.x.
22. Reddy, S. T., et al. (2007). Third-year medical students' participation in and perceptions of unprofessional behaviors. Academic Medicine, 82, S35-S39.
23. Reuler, J. B., & Nardone, D. A. (1994). Role modeling in medical education. The Western Journal of Medicine, 160, 335-337.
24. Rogers, W. A., et al. (2004). The ethics of pharmaceutical industry relationships with medical students. The Medical Journal of Australia, 180, 411-414.
25. Sandberg, W. S., et al. (1997). The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products. Academic Medicine, 72, 916-918. doi:10.1097/00001888-199710000-00018.
26. Shear, N., et al. (1996). Examining the physician-detailer interaction. The Canadian Journal of Clinical Pharmacology, 3, 175-179.
27. Sierles, F. S., et al. (2005). Medical students' exposure to and attitudes about drug company interactions: A national survey. Journal of the American Medical Association, 294, 1034-1042. doi:10.1001/jama.294.9.1034.
28. Suryawati, S., & Santoso, B. (1997). Drug advertisements: A critical lesson for Indonesian students. Essential Drugs Monitor, 23, 23.
29. Vainiomaki, M., et al. (2004). A national survey on the effect of pharmaceutical promotion on medical students. Medical Teacher, 26, 630-634. doi:10.1080/01421590400004890.
30. Vinson, D. C., et al. (1993). Medical students' attitudes toward pharmaceutical marketing: Possibilities for change. Family Medicine, 25, 31-33.
31. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 283, 373-380. doi:10.1001/jama.283.3.373.
32. Westfall, J. M. (2000). Physicians, pharmaceutical representatives, and patients: Who really benefits? The Journal of Family Practice, 49, 817-819.
33. Wilkes, M. S., & Hoffman, J. R. (2001). An innovative approach to educating medical students about pharmaceutical promotion. Academic Medicine, 76, 1271-1277. doi:10.1097/00001888-200112000-00026.
34. Wofford, J. L., & Ohl, C. A. (2005). Teaching appropriate interactions with pharmaceutical company representatives: The impact of an innovative workshop on student attitudes. BMC Medical Education, 5, 5. doi:10.1186/1472-6920-5-5.
35. Wright, S., et al. (1997). The impact of role models on medical students. Journal of General Internal Medicine, 12, 53-56. doi:10.1007/s11606-006-0007-1.